Pharm'Up
In a significant move to reduce its dependence on imports and strengthen domestic manufacturing, the Government of...
In a new study published in Current Research in Structural Biology, investigators have identified two natural alkaloids...
New data from the phase 3 ATTAIN-1 trial (NCT05869903) has shown that orforglipron, an investigational once-daily oral...
A recent study published in the International Journal of Medical Sciences has uncovered a compelling link between...
Prescription Product Milestones August 2025 marks a period of significant advancements in the pharmaceutical landscape, with the...
Boan Biotech’s new biosimilar, LY05008, has been shown to have comparable efficacy and safety to its reference...
The ASTER 70s trial, a phase 3 study published in The Lancet, has provided crucial new evidence...
Culturally tailored education is more than just translated materials; it’s a powerful tool for empowering patients with...
A new study published in Nature Communications has found that giving probiotic supplements to very-low-birth-weight (VLBW) preterm...
Palbociclib (Ibrance) has become a cornerstone in the treatment of advanced hormone receptor-positive (HR+), HER2-negative (HER2–) breast...
